Portfolio Companies 2026 for Bristol Myers Squibb: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Bristol Myers Squibb accounts for 24 tracked companies with verified cap-table data, 24 of which disclose round sizes totalling $3.5B. The median disclosed raise is $135M, and the largest is TORL BioTherapeutics at $450M, ahead of Metagenomi ($300M) and Asher Bio ($215M).
The names that recur most often on these portfolio cap tables are Bristol Myers Squibb (24 companies), Alexandria Venture Investments (7 companies), Leaps by Bayer (3 companies), GV (3 companies), Pfizer Ventures (3 companies), Deep Track Capital (2 companies). By latest disclosed round, the market skews Series B (12), Series A (8), Series C (4).
Companies tracked: 24
Disclosed funding total: $3.5B across 24 companies
